Lionhunter Capital Management, LLC’s GSK GSK Stock Holding History

Lionhunter Capital Management, LLC’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$416K	Buy	+7,932	New	+$419K	0.19%	86

Other funds holding GSK

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $44.4B AUM 36.05% 1-Year Est. Return

Lionhunter Capital Management, LLC's GSK Position: Q2 2026 in Review

Lionhunter Capital Management, LLC opened a new position in GSK (GSK) in Q2 2026: 7,932 shares worth $416K. The stake represents 0.19% of the portfolio and ranks #86 among its holdings.

878 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

Lionhunter Capital Management, LLC held 7,932 shares of GSK worth $416K as of Q2 2026.
GSK was a new Lionhunter Capital Management, LLC position in Q2 2026.
GSK made up 0.19% of Lionhunter Capital Management, LLC's portfolio in Q2 2026, its #86 holding.
878 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Lionhunter Capital Management, LLC's 13F filing for Q2 2026, filed 13 Aug 2026.